메뉴 건너뛰기




Volumn 17, Issue 4, 2008, Pages 195-200

Combined ultrasound and biochemical screening for fetal aneuploidy at 10 - 14 weeks of pregnancy: First results of test performance in Croatia;Kombinirani ultrazvučno-biokemijski probir fetalnih aneuploidija od 10. - 14. tjedna trudnoce: Prvirezultati primjene testa u hrvatskoj

(27)  Tišlarić Medenjak, Dubravka a   Košec, Vesna a   Kos, Milan b   Latin, Višnja b   Harni, Vesna b   Lovrić, Boris b   Tučkar, Neven a   Sabolović Rudman, Senka a   Herman, Radoslav a   Končar, Mišo b   Duić, Željko a   Podobnik, Mario b   Ljubojević Grgec, Dragano b   Soljačić Vraneš, Hrvojka a   Tonković Durišević, Ivana c   Gudelj, Maja b   Morton, Ulla b   Lončar, Milorad b   Rajhvajn, Branko b   Majnarić, Dario b   more..


Author keywords

First trimester screening; Free hCG; Nuchal translucency; PAPP A; Syndrome down

Indexed keywords


EID: 70350246906     PISSN: 13300091     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (6)

References (28)
  • 1
    • 0032415271 scopus 로고    scopus 로고
    • Screening for Down's syndrome and neural tube defect in Croatia: A regional prospective study
    • Brajenović-Milić B, Tišlarić D, Bačić J et al. Screening for Down's syndrome and neural tube defect in Croatia: A regional prospective study. Fetal DiagTher 1998;13:367-71.
    • (1998) Fetal DiagTher , vol.13 , pp. 367-371
    • Brajenović-Milić, B.1    Tišlarić, D.2    Bačić, J.3
  • 2
    • 0033988362 scopus 로고    scopus 로고
    • The triple marker test in predictig fetal aneuploićy: A compromise between sensitivity and specificity
    • Huderer-Durić K, Škrablin S, Kuvačić I et al. The triple marker test in predictig fetal aneuploićy: A compromise between sensitivity and specificity. Eur J Obstet Gynaecol Reprod Biol 2000;88:49-55.
    • (2000) Eur J Obstet Gynaecol Reprod Biol , vol.88 , pp. 49-55
    • Huderer-Durić, K.1    Škrablin Kuvačić, S.I.2
  • 3
    • 0026787127 scopus 로고
    • Ultrasono-graphically detectable markers of fetal chromosomal abnormalities
    • Nicolaides KH, Snijders RJ, Gosden CM et al. Ultrasono-graphically detectable markers of fetal chromosomal abnormalities. Lancet 1992;340:704-7.
    • (1992) Lancet , vol.340 , pp. 704-707
    • Nicolaides, K.H.1    Snijders, R.J.2    Gosden, C.M.3
  • 4
    • 0032146382 scopus 로고    scopus 로고
    • UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal translucency thickness at 10-14 weeks of gestation
    • Snijders RJ, Noble P, Sebire N et al. UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal translucency thickness at 10-14 weeks of gestation. Lancet 1998;351:343-6.
    • (1998) Lancet , vol.351 , pp. 343-346
    • Snijders, R.J.1    Noble, P.2    Sebire, N.3
  • 5
    • 15944409220 scopus 로고    scopus 로고
    • Multicenter study in first trimester screening for trisomy 21 in 75.821 pregnancies: Results and estimation of the potential impact of individual risk-oriented two stage first-trimester screening
    • Nicolaides KH, Spencer K, Avigdon K et al. Multicenter study in first trimester screening for trisomy 21 in 75.821 pregnancies: Results and estimation of the potential impact of individual risk-oriented two stage first-trimester screening. Ultrasound Obstet Gynecol 2005;25:221-6.
    • (2005) Ultrasound Obstet Gynecol , vol.25 , pp. 221-226
    • Nicolaides, K.H.1    Spencer, K.2    Avigdon, K.3
  • 6
    • 0036261150 scopus 로고    scopus 로고
    • Increased fetal translucency at 11-14 weeks
    • Nicolaides KH, Heath V, Cicero S. Increased fetal translucency at 11-14 weeks. Prenat Diagn 2002;22:308-15.
    • (2002) Prenat Diagn , vol.22 , pp. 308-315
    • Nicolaides, K.H.1    Heath, V.2    Cicero, S.3
  • 7
    • 0032710295 scopus 로고    scopus 로고
    • Screening for trisomy 18 by fetal nuchal translucency and maternal serum free beta hCG, PAPP-A at 10-14 weeks of gestation
    • Tul N, Spencer K, Noble P et al. Screening for trisomy 18 by fetal nuchal translucency and maternal serum free beta hCG, PAPP-A at 10-14 weeks of gestation. Prenat Diagn 1999;19: 1035-42.
    • (1999) Prenat Diagn , vol.19 , pp. 1035-1042
    • Tul, N.1    Spencer, K.2    Noble, P.3
  • 8
    • 0032999749 scopus 로고    scopus 로고
    • A screening program for trisomy 21 at 10-14 weeks using fetal nuchal translucency, maternal serum free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A
    • Spencer K, Souter V, Tul N et al. A screening program for trisomy 21 at 10-14 weeks using fetal nuchal translucency, maternal serum free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A. Ultrasound Obstet Gynecol 1999;13:231-7.
    • (1999) Ultrasound Obstet Gynecol , vol.13 , pp. 231-237
    • Spencer, K.1    Souter, V.2    Tul, N.3
  • 9
    • 20444468193 scopus 로고    scopus 로고
    • Prospective first-trimester screening for trisomy 21 in 30.564 pregnancies
    • Avigdon K, Papageorghiou A, Bindra R et al. Prospective first-trimester screening for trisomy 21 in 30.564 pregnancies. Am J Obstet Gynecol 2005; 192:1761-7.
    • (2005) Am J Obstet Gynecol , vol.192 , pp. 1761-1767
    • Avigdon, K.1    Papageorghiou, A.2    Bindra, R.3
  • 10
    • 0036796080 scopus 로고    scopus 로고
    • A first trimester trisomy 13/ trisomy 18 algorhytm combining fetal translucency thickness, maternal serum free β-hCG and PAPP-A
    • Spencer K, Nicolaides KH. A first trimester trisomy 13/ trisomy 18 algorhytm combining fetal translucency thickness, maternal serum free β-hCG and PAPP-A. Prenat Diagn 2003; 22:877-9.
    • (2003) Prenat Diagn , vol.22 , pp. 877-879
    • Spencer, K.1    Nicolaides, K.H.2
  • 11
    • 70350229545 scopus 로고    scopus 로고
    • New guidelines recommend universal prenatal screening for Down syndrome
    • Barclay L, Lie D. New guidelines recommend universal prenatal screening for Down syndrome. Obstet Gynecol 2007; 109:217-28.
    • (2007) Obstet Gynecol , vol.109 , pp. 217-228
    • Barclay, L.1    Lie, D.2
  • 12
    • 0033795008 scopus 로고    scopus 로고
    • One stop clinic for assessment for fetal anomalies: A report of the first year of prospective screening for chromosomal anomalies in the first trimester
    • Spencer K, Spencer CE, Power M et al. One stop clinic for assessment for fetal anomalies: A report of the first year of prospective screening for chromosomal anomalies in the first trimester. Br J Obstet Gynaecol 2000;107:1271-5.
    • (2000) Br J Obstet Gynaecol , vol.107 , pp. 1271-1275
    • Spencer, K.1    Spencer, C.E.2    Power, M.3
  • 14
    • 0037393802 scopus 로고    scopus 로고
    • Integrated ultrasound and biochemical screening for trisomy 21 using fetal translucency, absent fetal nasal bone, free β-hCG and PAPP-A at 11 to 14 weeks
    • Cicero S, Bindra R, Rembouskos G et al. Integrated ultrasound and biochemical screening for trisomy 21 using fetal translucency, absent fetal nasal bone, free β-hCG and PAPP-A at 11 to 14 weeks. Prenat Diagn 2003;23:306-10.
    • (2003) Prenat Diagn , vol.23 , pp. 306-310
    • Cicero, S.1    Bindra, R.2    Rembouskos, G.3
  • 15
    • 27144504477 scopus 로고    scopus 로고
    • First trimester screening for Down syndrome with Ductus venosus Doppler studies in addition to nuchal translucency and serum markers
    • Borrel A, Gonce A, Martinez JM et al. First trimester screening for Down syndrome with Ductus venosus Doppler studies in addition to nuchal translucency and serum markers. Prenat Diagn 2005;25:901-5.
    • (2005) Prenat Diagn , vol.25 , pp. 901-905
    • Borrel, A.1    Gonce, A.2    Martinez, J.M.3
  • 16
    • 0041326790 scopus 로고    scopus 로고
    • Tricuspid regurgitation in the diagnosis of chromosomal anomalies in the fetus at 11-14 weeks of gestation
    • Huggon IC, De Figuereido DB, Allan LD. Tricuspid regurgitation in the diagnosis of chromosomal anomalies in the fetus at 11-14 weeks of gestation. Heart 2003;89:1071-3.
    • (2003) Heart , vol.89 , pp. 1071-1073
    • Huggon, I.C.1    De Figuereido, D.B.2    Allan, L.D.3
  • 18
    • 0038366552 scopus 로고    scopus 로고
    • The effect of temporal variations of biochemical markers of trisomy 21 ac-cross the first and second trimester of pregnancy on the estimation of individual patient-specific risks and detection rates for Down's syndrome
    • Spencer K, Crossley JA, Aitken DA et al. The effect of temporal variations of biochemical markers of trisomy 21 ac-cross the first and second trimester of pregnancy on the estimation of individual patient-specific risks and detection rates for Down's syndrome. Ann Clin Biochem 2003;40:219-31.
    • (2003) Ann Clin Biochem , vol.40 , pp. 219-231
    • Spencer, K.1    Crossley, J.A.2    Aitken, D.A.3
  • 19
    • 8244243721 scopus 로고
    • A critical evaluation of sonar, crown-rump length measurement by ultrasoud in normal pregnancy
    • Robinson HP, Fleming JEE. A critical evaluation of sonar crown-rump length measurement by ultrasoud in normal pregnancy. Br J Obstet Gynaecol 1975;82:702-10.
    • (1975) Br J Obstet Gynaecol , vol.82 , pp. 702-710
    • Robinson, H.P.1    Fleming, J.E.E.2
  • 20
    • 0006951772 scopus 로고    scopus 로고
    • Correct estimation of parameters for ultrasound nuchal translucency screening
    • Nicolaides KH, Snijders RJ, Cukle RS. Correct estimation of parameters for ultrasound nuchal translucency screening. Prenat Diagn 1998;18:519-23.
    • (1998) Prenat Diagn , vol.18 , pp. 519-523
    • Nicolaides, K.H.1    Snijders, R.J.2    Cukle, R.S.3
  • 21
    • 0036126080 scopus 로고    scopus 로고
    • The first trimester 'combined test' for the detection of Down syndrome pregnancies in 4939 unselected pregnancies
    • Schuster K, Hafher E, Stengl G et al. The first trimester 'combined test' for the detection of Down syndrome pregnancies in 4939 unselected pregnancies. Prenat Diagn 2002;22:211-5.
    • (2002) Prenat Diagn , vol.22 , pp. 211-215
    • Schuster, K.1    Hafher, E.2    Stengl, G.3
  • 22
    • 0142073802 scopus 로고    scopus 로고
    • First-trimester screening for Down syndrome in France combining fetal translucency measurement and biochemical markers
    • Muller F, Benattar C, Audibert F et al. First-trimester screening for Down syndrome in France combining fetal translucency measurement and biochemical markers. Prenat Diagn 2003;23:833-6.
    • (2003) Prenat Diagn , vol.23 , pp. 833-836
    • Muller, F.1    Benattar, C.2    Audibert, F.3
  • 23
    • 0037333249 scopus 로고    scopus 로고
    • Screening for chromosomal abnormalities in the first trimester using ultrasound and maternal serum biochemistry in a one-stop clinic: A review of three years prospective experience
    • DOI 10.1046/j.1471-0528.2003.02246.x
    • Spencer K, Nicolaides KH. Serening for chromosome abnormalities in the first trimester using ultrasound and maternal serum biochemistry in one-stop clinic: a review of three years prospective experience. Br J Obstet Gynaecol 2003; 110:281-6. (Pubitemid 36298912)
    • (2003) BJOG: An International Journal of Obstetrics and Gynaecology , vol.110 , Issue.3 , pp. 281-286
    • Spencer, K.1    Spencer, C.E.2    Power, M.3    Dawson, C.4    Nicolaides, K.H.5
  • 24
    • 33847376999 scopus 로고    scopus 로고
    • Clinical first-trimester routine screening for Down syndrome in singleton pregnancies in Northern Finland
    • Valinen Y, Rapukko K, Kokkonen H et al. Clinical first-trimester routine screening for Down syndrome in singleton pregnancies in Northern Finland. Am J Obstet Gynecol 2007; 196: 278el-278e5.
    • (2007) Am J Obstet Gynecol , vol.196
    • Valinen, Y.1    Rapukko, K.2    Kokkonen, H.3
  • 25
    • 0034792982 scopus 로고    scopus 로고
    • Age related detection and false positive rates when screening for Down's syndrome in the first trimester using fetal nuchal translucency and maternal serum free β-hCG and PAPP-A
    • Spencer K. Age related detection and false positive rates when screening for Down's syndrome in the first trimester using fetal nuchal translucency and maternal serum free β-hCG and PAPP-A. Br J Obstet Gynaecol 2001;108:1043-6.
    • (2001) Br J Obstet Gynaecol , vol.108 , pp. 1043-1046
    • Spencer, K.1
  • 26
    • 17344382242 scopus 로고    scopus 로고
    • Probir dvostrukim biokemijskim testom
    • TiSlarić-Medenjak D. Probir dvostrukim biokemijskim testom. Gynaecol Perinatol 2003;12(suppl.1):68-71.
    • (2003) Gynaecol Perinatol , vol.12 , Issue.SUPPL.1 , pp. 68-71
    • Tišlarić-Medenjak, D.1
  • 27
    • 23644445294 scopus 로고    scopus 로고
    • Evidence-based obstetric ethics and informed decision-making by pregnant women about invasive diagnosis after first-trimester assessment of risk for trisomy 21
    • Nicolaides KH, Chervenak FA, McCullough LB et al. Evidence-based obstetric ethics and informed decision-making by pregnant women about invasive diagnosis after first-trimester assessment of risk for trisomy 21. Am J Obstet Gynecol 2005; 193:322-6.
    • (2005) Am J Obstet Gynecol , vol.193 , pp. 322-326
    • Nicolaides, K.H.1    Chervenak, F.A.2    McCullough, L.B.3
  • 28
    • 78650606974 scopus 로고    scopus 로고
    • The prevalence of live birth Down syndrome in the region of Primorsko-goranska County in Croatia 1996-2005: The impact of screening and amniocentesis
    • Brajenović-Milić B, Prpić I, Petrović O et al. The prevalence of live birth Down syndrome in the region of Primorsko-goranska County in Croatia, 1996-2005: The impact of screening and amniocentesis. Maternal and Child Health Journal (u tisku).
    • Maternal and Child Health Journal (U Tisku)
    • Brajenović-Milić, B.1    Prpić, I.2    Petrović, O.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.